The groundbreaking treatment of the medication represents a exciting development in the handling of type 2 diabetes. Unlike existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide836021.blogdanica.com/42194384/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment